Meeting
2018 Gastrointestinal Cancers Symposium
Prognostic value of neutrophil-lymphocyte ratio during palliative chemotherapy in patients with unresectable gallbladder adenocarcinoma.
Authors
Jae Woo Lee
Mediplex Sejong Hospital, Incheon, Korea, Republic of (South)
Jae Woo Lee , Sang Hyub Lee , Jun Hyuk Son , Jinwoo Kang , Woo Hyun Paik , Ji Kon Ryu , Yong-Tae Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 253)
DOI
10.1200/JCO.2018.36.4_suppl.253
Abstract #
253
Poster Bd #
C6
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Impact of risk factors on overall survival (OS) in patients (pts) with unresectable hepatocellular carcinoma (HCC) treated with first-line (1L) tislelizumab (TIS).
First Author: Masatoshi Kudo
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic biomarkers in unresectable hepatocellular carcinoma (HCC) treated with atezolizumab plus bevacizumab (atezo-bev).
First Author: Linda Wu
Poster
2019 Genitourinary Cancers Symposium
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for overall survival in men with advanced prostate cancer treated with platinum chemotherapy.
First Author: Panagiotis J. Vlachostergios
Poster
2019 Gastrointestinal Cancers Symposium
Prognostic significance of nutritional and inflammatory markers in patients with unresectable pancreatic ductal adenocarcinoma treated with chemotherapy.
First Author: Ryosuke Kobiyama